vs

Side-by-side financial comparison of Brookfield Infrastructure Corp (BIPC) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Brookfield Infrastructure Corp is the larger business by last-quarter revenue ($866.0M vs $665.5M, roughly 1.3× Natera, Inc.). Natera, Inc. runs the higher net margin — 7.1% vs -35.7%, a 42.8% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -4.6%).

Brookfield Infrastructure Partners L.P. is a publicly traded limited partnership with corporate headquarters in Toronto, Canada, that engages in the acquisition and management of infrastructure assets on a global basis.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

BIPC vs NTRA — Head-to-Head

Bigger by revenue
BIPC
BIPC
1.3× larger
BIPC
$866.0M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+44.4% gap
NTRA
39.8%
-4.6%
BIPC
Higher net margin
NTRA
NTRA
42.8% more per $
NTRA
7.1%
-35.7%
BIPC

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BIPC
BIPC
NTRA
NTRA
Revenue
$866.0M
$665.5M
Net Profit
$-309.0M
$47.3M
Gross Margin
65.0%
Operating Margin
62.7%
-3.4%
Net Margin
-35.7%
7.1%
Revenue YoY
-4.6%
39.8%
Net Profit YoY
-148.1%
187.9%
EPS (diluted)
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIPC
BIPC
NTRA
NTRA
Q4 25
$665.5M
Q3 25
$592.2M
Q2 25
$866.0M
$546.6M
Q1 25
$501.8M
Q4 24
$476.1M
Q3 24
$439.8M
Q2 24
$908.0M
$413.4M
Q1 24
$367.7M
Net Profit
BIPC
BIPC
NTRA
NTRA
Q4 25
$47.3M
Q3 25
$-87.5M
Q2 25
$-309.0M
$-100.9M
Q1 25
$-66.9M
Q4 24
$-53.8M
Q3 24
$-31.6M
Q2 24
$643.0M
$-37.5M
Q1 24
$-67.6M
Gross Margin
BIPC
BIPC
NTRA
NTRA
Q4 25
Q3 25
Q2 25
65.0%
Q1 25
Q4 24
Q3 24
Q2 24
63.8%
Q1 24
Operating Margin
BIPC
BIPC
NTRA
NTRA
Q4 25
-3.4%
Q3 25
-16.5%
Q2 25
62.7%
-20.2%
Q1 25
-15.8%
Q4 24
-13.6%
Q3 24
-8.9%
Q2 24
61.9%
-10.6%
Q1 24
-20.2%
Net Margin
BIPC
BIPC
NTRA
NTRA
Q4 25
7.1%
Q3 25
-14.8%
Q2 25
-35.7%
-18.5%
Q1 25
-13.3%
Q4 24
-11.3%
Q3 24
-7.2%
Q2 24
70.8%
-9.1%
Q1 24
-18.4%
EPS (diluted)
BIPC
BIPC
NTRA
NTRA
Q4 25
$0.36
Q3 25
$-0.64
Q2 25
$-0.74
Q1 25
$-0.50
Q4 24
$-0.41
Q3 24
$-0.26
Q2 24
$-0.30
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIPC
BIPC
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$1.2B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.2B
$1.7B
Total Assets
$23.9B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIPC
BIPC
NTRA
NTRA
Q4 25
Q3 25
$1.0M
Q2 25
$1.2B
$16.0M
Q1 25
$17.8M
Q4 24
$22.7M
Q3 24
$29.5M
Q2 24
$466.0M
$90.3M
Q1 24
$69.1M
Stockholders' Equity
BIPC
BIPC
NTRA
NTRA
Q4 25
$1.7B
Q3 25
$1.3B
Q2 25
$2.2B
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$878.5M
Q2 24
$3.5B
$836.5M
Q1 24
$794.1M
Total Assets
BIPC
BIPC
NTRA
NTRA
Q4 25
$2.4B
Q3 25
$1.8B
Q2 25
$23.9B
$1.8B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.6B
Q2 24
$23.7B
$1.5B
Q1 24
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIPC
BIPC
NTRA
NTRA
Operating Cash FlowLast quarter
$478.0M
$73.9M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIPC
BIPC
NTRA
NTRA
Q4 25
$73.9M
Q3 25
$59.4M
Q2 25
$478.0M
$37.6M
Q1 25
$44.5M
Q4 24
$52.9M
Q3 24
$51.8M
Q2 24
$511.0M
$4.0M
Q1 24
$27.0M
Free Cash Flow
BIPC
BIPC
NTRA
NTRA
Q4 25
$37.8M
Q3 25
$37.0M
Q2 25
$11.7M
Q1 25
$22.6M
Q4 24
$34.8M
Q3 24
$35.5M
Q2 24
$-7.7M
Q1 24
$6.7M
FCF Margin
BIPC
BIPC
NTRA
NTRA
Q4 25
5.7%
Q3 25
6.2%
Q2 25
2.1%
Q1 25
4.5%
Q4 24
7.3%
Q3 24
8.1%
Q2 24
-1.9%
Q1 24
1.8%
Capex Intensity
BIPC
BIPC
NTRA
NTRA
Q4 25
5.4%
Q3 25
3.8%
Q2 25
4.7%
Q1 25
4.3%
Q4 24
3.8%
Q3 24
3.7%
Q2 24
2.8%
Q1 24
5.5%
Cash Conversion
BIPC
BIPC
NTRA
NTRA
Q4 25
1.56×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.79×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons